TIMP-2 and IGFBP7 for the Prediction of the Cardiac Surgery Associated Acute Kidney Injury
Novel Biomarkers (TIMP-2 and IGFBP7) of Tubular Renal Cell Damage for the Prediction of the Cardiac Surgery Associated Acute Kidney Injury (CSA-AKI) - A Feasibility Study
1 other identifier
observational
110
1 country
1
Brief Summary
The purpose of this study is to analyze the new biomarkers (TIMP-2 and IGFBP-7) of tubular renal cell damage for the prediction of the Cardiac Surgery Associated acute kidney injury.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2013
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2013
CompletedFirst Submitted
Initial submission to the registry
February 3, 2014
CompletedFirst Posted
Study publicly available on registry
February 4, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2014
CompletedFebruary 27, 2015
February 1, 2015
1 year
February 3, 2014
February 26, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
AKI-stadium 1 (KDIGO)
30 days
Secondary Outcomes (1)
all cause mortality
30 days
Other Outcomes (1)
AKI Stadium 2-3 (KDIGO)
30 days
Eligibility Criteria
adults with planned cardiac surgery and cardiopulmonary bypass
You may qualify if:
- planned cardiac surgery
You may not qualify if:
- renal dialysis
- minors
- emergency
- no cardiopulmonary bypass
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universitätsspital Basel
Basel, Canton of Basel-City, 4056, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jens Fassl, MD
University Hospital, Basel, Switzerland
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 3, 2014
First Posted
February 4, 2014
Study Start
December 1, 2013
Primary Completion
December 1, 2014
Study Completion
December 1, 2014
Last Updated
February 27, 2015
Record last verified: 2015-02